Virtus Biotech ETF
BBP
15 hedge funds and large institutions have $9.68M invested in Virtus Biotech ETF in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
4.69% less ownership
Funds ownership: 43.2% → 38.51% (-4.7%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
29% less funds holding
Funds holding: 21 → 15 (-6)
36% less capital invested
Capital invested by funds: $15.1M → $9.68M (-$5.38M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$309K |
| 2 |
SMG
Smart Money Group
Eastland,
Texas
|
+$102K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$63.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$42.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
-$3.74M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$231K |
| 3 |
Jane Street
New York
|
-$198K |
| 4 |
JP Morgan Chase
New York
|
-$172K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$86.3K |
BBP Hedge Fund Activity: Q3 2019 in Review
15 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q3 2019, worth a combined $9.68M — down 36% from $15.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BBP and 0 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Royal Bank of Canada, adding an estimated $309K. The largest seller was RPg Family Wealth Advisory, exiting entirely with an estimated $3.74M sold.
- 15 institutional investors held Virtus Biotech ETF (BBP) as of Q3 2019, down from 21 in Q2 2019.
- Funds reported $9.68M of Virtus Biotech ETF stock for Q3 2019, down 36% quarter-over-quarter.
- 0 funds opened new Virtus Biotech ETF positions in Q3 2019 and 6 closed out, a net change of -6 holders.
- The largest Virtus Biotech ETF buyer in Q3 2019 was Royal Bank of Canada, an estimated $309K added.
- The largest Virtus Biotech ETF seller in Q3 2019 was RPg Family Wealth Advisory, an estimated $3.74M sold.
Based on aggregated 13F filings for Q3 2019.